NGL-Impact® A 配基

由 Repligen 和 Navigo 共同开发的新一代配基(NGL-Impact® A 配基)是一种革命性的解决方案,可为捕获层析提供更高性能、更低成本的 Protein A 填料。

Next Generation Protein A Ligand

Co-developed with Navigo Proteins, NGL-Impact® A Ligand from Repligen was developed through a series of steps, including wild type Protein A shuffling, screening and multimerization.  The result is a market-leading ligand that responds to the need for capture resins with better binding capacity, caustic stability and elution while reducing costs and improving process economics.

Repligen and Navigo will co-develop a portfolio of next generation ligands, utilizing Navigo’s proprietary Precision Capturing® technology platform.


Repligen entered an agreement to commercialize NGL-Impact® A  Ligand using Purolite novel Praesto® agarose jetting base bead technology. 

NGL-Impact® A has outstanding performance attributes when immobilized on jetted agarose bead technology, with ultra-high binding capacities and excellent alkaline stability. These attributes are important in providing improved monoclonal antibody capture to handle increased upstream product titres, and in allowing higher concentrations of sodium hydroxide (NaOH) for sanitization of resins.


The following data show the performance of Praesto Jetted A50 resin from Purolite, which uses the NGL-Impact® A ligand, compared with standard industry capture resins.

Manufacturing Centers of Excellence

Repligen在ISO 9001质量管理体系下开发和生产用于生物制药行业的产品。我们专注于及时交付高质量、一致且稳健的产品,以确保我们客户的业务连续性。

Repligen manufacturing sites are located in Massachusetts, California, and New Jersey in the United States and in Sweden, France, The Netherlands,  Germany and Estonia.